all news

Fri, 11 Oct 2024 GlobeNewswire

CAMP4 Announces Pricing of Initial Public Offering

Tue, 8 Oct 2024 Associated Press

Cohere Health and MCG Partner to Deliver Best-in-Class Prior Authorization Solution

Tue, 8 Oct 2024 GlobeNewswire

KSQ Therapeutics Appoints Anna Truppel-Hartmann, M.D., as Chief Medical Officer

Mon, 7 Oct 2024 Associated Press

BeMe Health Partners with Rock the Vote to Support Gen Z Voters' Mental Health

Mon, 7 Oct 2024 Yahoo! Finance

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease

Mon, 7 Oct 2024 Associated Press

Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)

Thu, 3 Oct 2024 Newsdirect.com

PathAI Announces Collaboration with the Crohn’s & Colitis Foundation to Advance Novel IBD Research and Development

Wed, 2 Oct 2024 Associated Press

Volastra Therapeutics Granted FDA Fast Track Designation for Novel KIF18A Inhibitor in Ovarian Cancer

Wed, 2 Oct 2024 PR Newswire

Triveni Bio Raises $115 Million Series B Financing to Expand Pipeline of Therapeutics Addressing Immunological and Inflammatory (I&I) Disorders

Wed, 2 Oct 2024 Podimetrics

Arbital Health and Podimetrics Partner on Value-Based Care Initiatives

Fri, 27 Sep 2024 PRNewswire - FinancialContent

Cardurion Pharmaceuticals Selected as an Endpoints 11 Most Promising Biotech Company

Thu, 26 Sep 2024 Seismic Therapeutic

Seismic Therapeutic Appoints Julie Eastland as Independent Board Director - Seismic Therapeutic

Thu, 26 Sep 2024 KSQ Therapeutics -

KSQ Therapeutics Announces FDA Clearance of IND Application for KSQ-004EX, a CRISPR/Cas9 Engineered Tumor-Infiltrating Lymphocyte (eTIL®) Th

Thu, 26 Sep 2024 Business Wire

Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors

Tue, 24 Sep 2024 GlobeNewswire

Bats Reveal Superior Adaptation to Endure Heart Stress: National Heart Centre Singapore Partners Paratus Sciences Singapore to Accelerate Heart Failure Care

Mon, 23 Sep 2024 The Business Journals

Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans

Mon, 23 Sep 2024 Yahoo! Finance

Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer

Mon, 23 Sep 2024 Associated Press

Seismic Therapeutic Appoints Julie Eastland as Independent Board Director

Mon, 23 Sep 2024 PRNewswire - FinancialContent

Ankyra Announces Appointment of Dr. Julia Butchko and Ms. Tara Withington to the Board of Directors

Fri, 20 Sep 2024 Tectonic Therapeutic

Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 : Tectonic Therapeutic

Thu, 19 Sep 2024 PR Newswire

QurAlis Announces Expansion of its Selective Kv7.2/7.3 Ion Channel Opener, QRL-101, Into Epilepsy

Fri, 13 Sep 2024 PR Newswire

Vico Therapeutics Announces Positive Interim Phase 1/2a Clinical Data of VO659 in Treatment of Huntington's Disease

Thu, 12 Sep 2024 Business Wire

Noetik Selected to Participate in the 2024 AWS Generative AI Accelerator

Thu, 12 Sep 2024 Associated Press

Unleashing Hope: Thrive Pet Healthcare and FidoCure Transform Canine Cancer Care

Tue, 10 Sep 2024 Kallyope

Kallyope Announces License Agreement with Novo Nordisk

Tue, 10 Sep 2024 Associated Press

QurAlis Doses First Participant Cohort in Phase 1 Multiple-Ascending Dose (MAD) Clinical Trial Evaluating QRL-101, a First-in-Class Kv7 Precision Therapy for ALS

Mon, 9 Sep 2024 Business Wire

Candid Therapeutics Debuts with $370M Capital Raise to Clinically Evaluate Potentially Transformative Autoimmune Therapies

Wed, 4 Sep 2024 Business Wire

Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer

Wed, 4 Sep 2024 Associated Press

Egnyte Appoints Prasad Gune as Chief Product Officer

Wed, 4 Sep 2024 Associated Press

Jnana Therapeutics Presents New Positive Data from Phase 1/2 Study of JNT-517 in Individuals with Phenylketonuria – Results Support Planned Pivotal Study in Early 2025